Impact of the COVID-19 Pandemic on Essential Vitreoretinal Care with Three Epicenters in the United States
- PMID: 32982151
- PMCID: PMC7490439
- DOI: 10.2147/OPTH.S267950
Impact of the COVID-19 Pandemic on Essential Vitreoretinal Care with Three Epicenters in the United States
Abstract
Purpose: To report the impact of COVID-19 on retina practices in three different "hot spot" cities in the United States.
Patients and methods: The authors assessed data of encounters and intravitreal injections from March 16th to May 8th 2020, at different offices specializing in retina in the United States. All three practices are located in COVID-19 hot spot zones. One practice was in an academic setting, one practice was in a private multispecialty setting, and one practice was a solo private vitreo-retina practice. All practices were focused on emergent/urgent care, and the results were compared to preCOVID-19 weekly averages.
Results: A significant decrease in the number of encounters and injections was revealed in all three centers involved in this review. There was a decrease of 87% in encounters (156 patients were seen only) and a decrease of 58% (126 patients) in intravitreal injections in Weill Cornell Medical College in NYC and a decline of 59% (569 patients) in encounters and a decrease of 64% (280 patients) of intravitreal injections at the Ophthalmic Consultants of Boston and Tufts University School of Medicine in Boston. The decline at Miami Ocular Oncology & Retina in Miami was 37% (1198 patients) in the encounters and 30% (867 patients) in the injections.
Conclusion: This manuscript documents a specific example illustrating that COVID-19 has led to a significant decrease in specialized health services. The degree of infection and mortality rate at each hot spot had a direct impact on the practice volume; however, the type of practice setting also played a role.
Keywords: COVID-19; medical practice; ophthalmology; pandemic; retina.
© 2020 El Hamichi et al.
Conflict of interest statement
Aaron Gold reports personal fees from Regeneron, outside the submitted work. Jeffrey Heier reports personal fees from 4DMT, Adverum, Aerie, Aerpio, Aldeyra, Allegro, Alzheon, Annexon, Apellis, Asclepix, Aviceda, Beaver-Visitec, Eloxx, Galimedix, Genentech, Gyroscope, iRenix, jCyte, Kala, Kanghong, NGM, Notal Vision, Novartis, Ocugenix, Oculis, Ocunexus, Ocular Therapeutix, Palatin, Pfizer, Regeneron, Regenxbio, Santen, Scifluor, Shire, Stealth, Tyrogenex, Vinci, Voyant, grants from Aerie, Aerpio, Apellis, Genentech, Graybug, Gyroscope, Hemera, Janssen R&D, KalVista, Kanghong, Novartis, Ophthotech, Optovue, Regeneron, Regenxbio, Stealth, outside the submitted work. Szilard Kiss reports Consultant – Adverum, Alcon, Allergan, BioMarin, Novartis, Optos, Genentech/Roche, Regeneron; Research Funding – Allergan, Novartis, Optos, Genentech/Roche, Regeneron; Equity – Adverum, RegenXBio, Fortress Bio; Intellectual Property — Gene Therapy for AMD, T-Cells for CMV Retinitis. The authors report no other potential conflicts of interest for this work.
Figures
Similar articles
-
Frequency of Urgent or Emergent Vitreoretinal Surgical Procedures in the United States During the COVID-19 Pandemic.JAMA Ophthalmol. 2021 Apr 1;139(4):456-463. doi: 10.1001/jamaophthalmol.2021.0036. JAMA Ophthalmol. 2021. PMID: 33662093 Free PMC article.
-
Changes in patient visits and diagnoses in a large academic center during the COVID-19 pandemic.BMC Ophthalmol. 2021 Mar 20;21(1):139. doi: 10.1186/s12886-021-01886-7. BMC Ophthalmol. 2021. PMID: 33743634 Free PMC article.
-
Practice Patterns and Responsiveness to Simulated Common Ocular Complaints Among US Ophthalmology Centers During the COVID-19 Pandemic.JAMA Ophthalmol. 2020 Sep 1;138(9):981-988. doi: 10.1001/jamaophthalmol.2020.3237. JAMA Ophthalmol. 2020. PMID: 32777008 Free PMC article.
-
Real-world vitreoretinal practice patterns during the 2020 COVID-19 pandemic: a nationwide, aggregated health record analysis.Curr Opin Ophthalmol. 2020 Sep;31(5):427-434. doi: 10.1097/ICU.0000000000000692. Curr Opin Ophthalmol. 2020. PMID: 32740067 Review.
-
Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure.Graefes Arch Clin Exp Ophthalmol. 2021 Mar;259(3):567-574. doi: 10.1007/s00417-021-05097-0. Epub 2021 Feb 2. Graefes Arch Clin Exp Ophthalmol. 2021. PMID: 33528647 Free PMC article. Review.
Cited by
-
The Impact of COVID-19 on Diabetic Retinopathy Monitoring and Treatment.Curr Diab Rep. 2021 Sep 8;21(10):40. doi: 10.1007/s11892-021-01411-6. Curr Diab Rep. 2021. PMID: 34495377 Free PMC article. Review.
-
Effects of delay in anti-vascular endothelial growth factor intravitreal injections for neovascular age-related macular degeneration.Graefes Arch Clin Exp Ophthalmol. 2022 Jun;260(6):1907-1914. doi: 10.1007/s00417-021-05505-5. Epub 2022 Jan 11. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 35013800 Free PMC article.
-
Cytomegalovirus antiviral stewardship in the COVID-19 Era: Increasing complexity of prophylaxis and treatment and potential mitigation strategies.Transpl Infect Dis. 2021 Aug;23(4):e13586. doi: 10.1111/tid.13586. Epub 2021 Mar 15. Transpl Infect Dis. 2021. PMID: 33595158 Free PMC article. Review.
-
The Impact of Non-Ophthalmic Factors on Intravitreal Injections During the COVID-19 Lockdown.Clin Ophthalmol. 2021 Aug 28;15:3661-3668. doi: 10.2147/OPTH.S314840. eCollection 2021. Clin Ophthalmol. 2021. PMID: 34483654 Free PMC article.
-
Retina in the Age of COVID-19.Adv Ophthalmol Optom. 2021 Aug;6:187-200. doi: 10.1016/j.yaoo.2021.04.013. Epub 2021 Apr 27. Adv Ophthalmol Optom. 2021. PMID: 33937585 Free PMC article. Review. No abstract available.
References
-
- Centers for Disease Control and Prevention. CDC newsroom releases. Available from: https://www.cdc.gov/media. Accessed April17, 2020.
-
- American Academy of Ophthalmology (AAO). Important coronavirus updates for ophthalmologists, Available from: https://www.aao.org/headline/alert-important-coronavirus-context. Accessed April17, 2020.
-
- American Society of Retina Specialsts (ASRS). COVID-19 updates and resources. Available from: https://www.asrs.org/practice/asrs-member-alert-regarding-covid-19-pandemic. Accessed April17, 2020.
LinkOut - more resources
Full Text Sources